Purpose： To evaluate the implementation of a pharmacy-led tobacco cessation medication education protocol at discharge in a community hospital. Design： Single center, retrospective quality assessment study. Methods...Purpose： To evaluate the implementation of a pharmacy-led tobacco cessation medication education protocol at discharge in a community hospital. Design： Single center, retrospective quality assessment study. Methods： A retrospective review of a pharmacy-led protocol was completed from November 2016 through April 2017. Data from one year prior to implementation of the protocol was analyzed against the study group. Results： A total of 607 tobacco cessation medication education interventions were made during the study period, 379 patients （62.4%） were given an OTC （Over The Counter） NRT （Nicotine Replacement Therapy） recommendation upon discharge and 148 （24.4%） were referred to the Ohio Tobacco Quit Line. TJC （The Joint Commission） TOB-3/3a measure was met in 44.1% of patients during the study period compared to 0% in the comparator group. Of the 75 patients who were reached via follow-up phone call, 23 （30.7%） purchased an OTC NRT and 22 （29.3%） completely quit using tobacco. Conclusions： Pharmacy-led tobacco cessation interventions during hospitalizations have a positive impact on TJC TOB-3/3a quality measure results and quit rates post-discharge. Our results encourage future studies in this area to further establish the importance of pharmacist involvement in tobacco cessation, specifically in the hospital setting.展开更多
文摘Purpose： To evaluate the implementation of a pharmacy-led tobacco cessation medication education protocol at discharge in a community hospital. Design： Single center, retrospective quality assessment study. Methods： A retrospective review of a pharmacy-led protocol was completed from November 2016 through April 2017. Data from one year prior to implementation of the protocol was analyzed against the study group. Results： A total of 607 tobacco cessation medication education interventions were made during the study period, 379 patients （62.4%） were given an OTC （Over The Counter） NRT （Nicotine Replacement Therapy） recommendation upon discharge and 148 （24.4%） were referred to the Ohio Tobacco Quit Line. TJC （The Joint Commission） TOB-3/3a measure was met in 44.1% of patients during the study period compared to 0% in the comparator group. Of the 75 patients who were reached via follow-up phone call, 23 （30.7%） purchased an OTC NRT and 22 （29.3%） completely quit using tobacco. Conclusions： Pharmacy-led tobacco cessation interventions during hospitalizations have a positive impact on TJC TOB-3/3a quality measure results and quit rates post-discharge. Our results encourage future studies in this area to further establish the importance of pharmacist involvement in tobacco cessation, specifically in the hospital setting.
